Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1.
Gafvelin G, Thunberg S, Kronqvist M, Grönlund H, Grönneberg R, Troye-Blomberg M, Akdis M, Fiebig H, Purohit A, Horak F, Reisinger J, Niederberger V, Akdis CA, Cromwell O, Pauli G, Valenta R, van Hage M. Gafvelin G, et al. Among authors: kronqvist m. Int Arch Allergy Immunol. 2005 Sep;138(1):59-66. doi: 10.1159/000087358. Epub 2005 Aug 11. Int Arch Allergy Immunol. 2005. PMID: 16103688 Clinical Trial.
Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season.
van Hage-Hamsten M, Kronqvist M, Zetterström O, Johansson E, Niederberger V, Vrtala S, Grönlund H, Grönneberg R, Valenta R. van Hage-Hamsten M, et al. Among authors: kronqvist m. J Allergy Clin Immunol. 1999 Nov;104(5):969-77. doi: 10.1016/s0091-6749(99)70077-1. J Allergy Clin Immunol. 1999. PMID: 10550741
Vaccination with genetically engineered allergens prevents progression of allergic disease.
Niederberger V, Horak F, Vrtala S, Spitzauer S, Krauth MT, Valent P, Reisinger J, Pelzmann M, Hayek B, Kronqvist M, Gafvelin G, Grönlund H, Purohit A, Suck R, Fiebig H, Cromwell O, Pauli G, van Hage-Hamsten M, Valenta R. Niederberger V, et al. Among authors: kronqvist m. Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2(Suppl 2):14677-82. doi: 10.1073/pnas.0404735101. Epub 2004 Aug 13. Proc Natl Acad Sci U S A. 2004. PMID: 15310844 Free PMC article. Clinical Trial.
Higher immunoglobulin E antibody levels to recombinant Fel d 1 in cat-allergic children with asthma compared with rhinoconjunctivitis.
Grönlund H, Adédoyin J, Reininger R, Varga EM, Zach M, Fredriksson M, Kronqvist M, Szepfalusi Z, Spitzauer S, Grönneberg R, Valenta R, Hedlin G, van Hage M. Grönlund H, et al. Among authors: kronqvist m. Clin Exp Allergy. 2008 Aug;38(8):1275-81. doi: 10.1111/j.1365-2222.2008.03003.x. Epub 2008 May 12. Clin Exp Allergy. 2008. PMID: 18477016
Variability of IgE reactivity profiles among European mite allergic patients.
Weghofer M, Thomas WR, Kronqvist M, Mari A, Purohit A, Pauli G, Horak F, Grönlund H, van Hage M, Valenta R, Vrtala S. Weghofer M, et al. Among authors: kronqvist m. Eur J Clin Invest. 2008 Dec;38(12):959-65. doi: 10.1111/j.1365-2362.2008.02048.x. Eur J Clin Invest. 2008. PMID: 19021722
40 results